Cargo Therapeutics rises 2.2% in trading debut after IPO priced at low end of range
The stock of Cargo Therapeutics CRGX, +2.80%, a clinical-stage biotech specializing in cancer treatments, rose 2.2% in its trading debut ...
Read moreTag: Renaissance IPO ETF
IPO market readies for six-deal week, with four expected to raise more than $100 million
There were signs of life in the initial public offering on Monday with a lineup of six deals on tap ...
Read more
Sagimet Biosciences gives going public a second chance under new CEO
Biotech drug developer Sagimet Biosciences is taking another shot at going public, according to a filing with the Securities and ...
Read more
